These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28570665)

  • 1. PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice.
    Hirose T; Tanaka Y; Tanaka A; Sakai H; Sasaki Y; Shinohara N; Ohdan H
    PLoS One; 2017; 12(6):e0178765. PubMed ID: 28570665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells.
    Riggs JE; Stowers RS; Mosier DE
    J Exp Med; 1990 Aug; 172(2):475-85. PubMed ID: 2373989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of allogeneic liver sinusoidal endothelial cells specifically inhibits T-cell responses to cognate stimuli.
    Banshodani M; Onoe T; Shishida M; Tahara H; Hashimoto S; Igarashi Y; Tanaka Y; Ohdan H
    Cell Transplant; 2013; 22(9):1695-708. PubMed ID: 23050792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
    Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH
    J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.
    Ishida M; Iwai Y; Tanaka Y; Okazaki T; Freeman GJ; Minato N; Honjo T
    Immunol Lett; 2002 Oct; 84(1):57-62. PubMed ID: 12161284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.
    Stewart R; Morrow M; Hammond SA; Mulgrew K; Marcus D; Poon E; Watkins A; Mullins S; Chodorge M; Andrews J; Bannister D; Dick E; Crawford N; Parmentier J; Alimzhanov M; Babcook JS; Foltz IN; Buchanan A; Bedian V; Wilkinson RW; McCourt M
    Cancer Immunol Res; 2015 Sep; 3(9):1052-62. PubMed ID: 25943534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L2 is expressed on activated human T cells and regulates their function.
    Messal N; Serriari NE; Pastor S; Nunès JA; Olive D
    Mol Immunol; 2011 Sep; 48(15-16):2214-9. PubMed ID: 21752471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
    Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
    Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells].
    Wang G; Wang F; Li H; Zhang L; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):132-6. PubMed ID: 23388330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
    Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
    Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
    Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
    Salama AD; Chitnis T; Imitola J; Ansari MJ; Akiba H; Tushima F; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Exp Med; 2003 Jul; 198(1):71-8. PubMed ID: 12847138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
    Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
    Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
    Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
    PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
    Terrazas LI; Montero D; Terrazas CA; Reyes JL; Rodríguez-Sosa M
    Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
    J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.